Global Pharmaceutical Formulations Procurement Market Intelligence Report 2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–The “Global
Pharmaceutical Formulations – Procurement Market Intelligence Report”

report has been added to Research and Markets’ offering.

Global Pharmaceutical Formulations Market, provides up-to-date
information about market shifts and potential risks, as well as in-depth
knowledge of products and services, which can help in planning and in
executing category management activities. It focuses on the cost-saving
aspects of procurement and on providing insights that can lead to
optimization of category spend.

The pharmaceutical industry has been demonstrating excellence in new
product development such as reformulations of existing drugs for better
customer acceptance or novel formulation approaches to enhance
bioavailability and reduce time to market. Formulation enhancements can
help in reducing the frequency of administration. The use of new
delivery technologies can significantly improve patient experience,
reduce the volume required for each dosage, and minimize the
side-effects associated with the formulation.

One of the procurement best practices for buyers in the global
pharmaceutical formulations market is to is to use DOE for formulation
development. Buyers should engage with suppliers that use DOE, which is
an effective tool and can be useful in the entire formulation process.

According to the report, one of the key growth drivers for the global
pharmaceutical formulations market is the developments in formulation
enhancements which can help in reducing the frequency of administration.
The use of new delivery technologies can significantly improve patient
experience, reduce the volume required for each dosage, and minimize the
side-effects associated with the formulation.

Further, the report states that one of the key procurement challenges
faced by buyers is problems of non-compliance by suppliers.
Pharmaceutical companies are required to follow a host of regulations in
the region of operation as well as are subject to scrutiny by global
regulatory agencies.

Key Topics Covered:

PART 1: CATEGORY AT A GLANCE

PART 2: SCOPE OF THE REPORT

PART 3: MARKET INSIGHTS

  • Category Spend Analysis
  • Category Maturity by Regions
  • Demand-Supply Shifts
  • Regional Demand-Supply Snapshot
  • Global Molasses Production Hubs
  • Market Developments
  • Regional Impact of Trends
  • Key Category Growth Drivers and Corresponding Regional Impacts
  • Major Category Growth Constraints and Corresponding Regional Impacts
  • Key Current Technological Innovations
  • Major Regulatory Frameworks
  • Strategic Sustainability Practices
  • Porter’s Five Forces
  • PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

  • Supplier Operational Capability Matrix
  • Other Prominent Suppliers by Region: Operational Capability Matrix
  • Supplier Functional Capability Matrix
  • Other Prominent Suppliers by Region: Functional Capability Matrix
  • Key Clients/Partners
  • Supplier Cost Breakup
  • Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

  • Pricing Models Snapshot
  • Pricing Models – Pros and Cons
  • Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

  • Major Category Requirements
  • Major Procurement Pain Points
  • Category Sourcing Evolution Matrix
  • Procurement Best Practices
  • Cost-saving Opportunities
  • Supplier Selection Criteria
  • Category Negotiation Strategies
  • SLA Terms
  • Supplier Evaluation Criteria
  • Category Risk Analysis

PART 7: TOP FIVE SUPPLIERS

  • Pfizer CentreOne
  • Mylan
  • Boehringer Ingelheim
  • Lonza
  • Baxter

For more information about this report visit https://www.researchandmarkets.com/research/zpr4t2/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery